5 Sep 2024
StabiCaps™ for stable softgels
Softgels are among the fastest-growing dosage formats across healthcare. Producing them can be challenging, with cross-linking impairing shell stability. Coming with optimal physicochemical characteristics, StabiCaps™ is the proven solution for more stable softgels. This patented gelatin solution helps to limit cross-linking, enabling the formulation of robust, long-lasting pharmaceutical and nutraceutical softgels, even with reactive fillings.
Other content from ROUSSELOT SAS
Brochure
PDF 2.0 MB